R-S-S Course: Economic Evalulation of Cancer Drugs – October 3rd
July 21, 2022
f
Regulatory Scientific and Health Solutions (R-S-S) is hosting a course entitled, “Economic Evaluation of Cancer Drugs.” The course is aimed towards professionals in health economics and outcomes research (HEOR), market access, and clinical oncology. Attendees will learn about the development, application, and interpretation of economic models for cancer drugs. The course takes place at the Hilton London Watford, Watford, UK on Monday 3rd October 2022. Register by 1st August 2022 for an early bird discount.
According to R-S-S, course instructors include,
“Dr Ralph Crott, Author of Economic Evaluation of Cancer Drugs Using Clinical Trial and Real World Data (former Professor of Health Economics).
Dr Iftekhar Khan, Author of Economic Evaluation of Cancer Drugs (Ex MHRA/EMA expert statistical and joint NICE/MHRA assessor).
University of Warwick Health Economics Research Unit (Associate Professor of Medical Statistics and Health Economics).
Dr Khadija Rantell, Statistical Assessor MHRA/NICE (Joint Assessor).
Member of the FDA/MHRA Joint Working Party on Methods in Oncology Trials.”
To register, click here.
(Source: R-S-S, July 21st, 2022)